RE:RE:RE:RE:The LONG road... Almost thereI wouldn't count on China so much. They'll probably reverse engineer the treatment and come up with a similar PS and laser to avoid royalties. Maybe call it Sinolase. An adequate ACT knockoff with only slightly less safety and efficacy.
99942Apophis wrote: Longholder99 wrote: I don't know as much as some do on here. But why if the system works and the molecule is proven. Would any big pharm in their right mind allow other companies anywhere near Ruvidar and the patent suite Theralase owns. A JV and multiple licenses may be best for TLT long term. But a big cheque with many zeros and it all goes to X Pharma may be something nobody can stop. Depending how bad they want to own it all. The money could get pretty serious and much to say no to. Just saying.
Hi Longholder99, in my way of thinking on this is I don't believe any big pharma has much of a choice as Theralase has many to choose from as partners. Anyone of the pharmas that are asked to participate will likely control or run one or more of the following geographic location i.e. all of North America, South America, Europe, Russia & countries under its influence, Asia, China etc. Selected pharmas could be chosen by where their network is established. A possibility could be with pharmas that already have a NMIBC treatment with hospitals. Another possibility is pharmas could be chosen by how much they are willing to pay Theralase to be included seeing they might be one of the pharmas that has a treatment that will become obsolete. It could very likely just come down to being included into this revenue stream. By using multiple pharmas and sharing some of the wealth should establish co-operation.
Good for Theralase to use existing networks rather than creating one.